The Primary Causes Of Cervical Cancer Essay

The human papillomavirus (HPV) is a sexually transmitted disease (STD) that is very common throughout the United States and worldwide (World Health Organization (WHO), 2016). There are over 100 different forms of the virus with 13 of these types being capable of causing cancer (WHO, 2016). HPV can lead to the development of serious health problems. Theses health problems are especially an issue for adolescent women due to the highly increasing STD rates among this age group (Kostas-Polston, Johnson-Mallard & Berman, 2012). There is a vaccine for many of the common types of HPV, however, many parents are refusing to vaccinate their daughters for various reasons. With the rising cases of STDs, less birth

HPV is by far the most common sexually transmitted infection in the United States. Per the Centers for Disease Control and Prevention (CDC), 50 percent of all sexually active men and women will get it at some point in their lives, and 20 million already have it. A vaccine is available that prevents 70% of cervical cancers that arise from sexual intercourse. The human papillomavirus is unknowingly common and is diagnosed in 10,000 women a year, causing 4,000 deaths per year (“HPV Question and Answers”). If we take the responsibility to vaccinate young girls and boys, to be safe, we can eliminate many unnecessary deaths. This vaccine is a great discovery that should be put to good use, the HPV vaccine should be mandated in young teens everywhere.

Cervical cancer is a type of abnormal and malignant cell growth on the cervix (birth canal), which causes the common death for American Women. Infected by Human Papillomavirus (HPV) through sexual contact is the main contributor to cervical cancer. According to American Cancer Society’s (ACS) (2017) estimation, around 12,820 people will newly have cervical cancer and about 4,210 people will die from that in 2017. Therefore, it is urgent to decrease the rate of cervical cancer at women. A three-shot Gardasil series vaccine approved by the FDA for girls started to prevent cervical cancer in 2006. There are more than forty types of HPVs and the majority

You ask an adolescent now days if any of his friends have had sex, and the majority can say yes, but if you ask them how many of them were protected, or knew if the other person was tested negative for STD’s, most of them will just give you the shoulder shrug and say, “Well I don’t know, who cares anyways.” For this reason exactly vaccination from such an early start in children became an urgent need in the late 20th century and early 21st century, making it mandatory to receive Hep A and Hep B along with the other countless vaccines; however there is one that has been tried to make mandatory among girls, and it’s the HPV vaccine that is used to prevenet cervial cancer. In order to illuminate the public on the subject, two writers, health

According to the Centers for Disease Control and Prevention (CDC), Human papillomavirus (HPV) infects roughly 20 million individuals in the United States with 6.1 million new cases each year. There is no cure for HPV, only treatment for associated health problems. There are more than 30 strains of HPV that affect more than half of sexually active individuals in their lifetime. Public health risks involve several types of HPV leading to precancerous lesions and causing 70% of cervical cancer. Cervical cancer, the second most common cancer, affects many women globally. In the United States, nearly 10,000 women are diagnosed with cervical cancer annually and 3,700 of those women die. It has been reported by American Cancer Society that with early

Approximately 500,000 new cases of cervical cancer occur each year worldwide, 260,000 of which are fatal. In the U.S., it is estimated that there were over 9,700 cases of cervical cancer in 2006, and of these 3,700 resulted in deaths”. Vaccinations are one of the most successful public health approaches to preventing and controlling infectious diseases. According to the CDC Advisory Committee on Immunization Practices the vaccine has been proven to be virtually 100% effective against the two types of HPV that are responsible for some 70% of cervical cancers.

Cervical cancer is one of the highly popular disease for the women. Different programmes has been made up to fight against this deadly disease. New Zealand has one of the best screening programmes in the world. The establishment of National Cervical Cancer Screening Programme in NZ in 1990 had reduced a significant number of 60% of women who develop cervical cancer and who die from it since it was built. More than 1 million New Zealander women are enrolled in this programme and 95 % are eligible. The Cervical Cancer screening programme aims to; informing women about the importance of having the cervical screening tests; promoting cervical screening tests on a regular basis to women aged 20–70; ensuring high-quality and culturally appropriate services; supporting women with abnormal tests; ensuring there is regular monitoring to see that the goals of the programme are being met. The NCSP also acknowledges the importance of the Treaty of Waitangi in providing a screening programme that is successful for all New Zealand women.

Human Papilloma Virus (HPV) is the causative operator of cervical disease, which is a standout amongst the most unmistakable tumors in ladies. HPV is a sexually transmitted malady that can influence both men and ladies. The immunizer discovery systems uncovered that the greater part of the ladies (those that are sexually dynamic) worldwide and roughly 70% of the sexually dynamic ladies of US populace have been presented to the papilloma infection sooner or later in time. The African area is having the most astounding rate of commonness with an expected number of 379153 cases amid the year 2000.

HPV, an abbreviation for human papilloma virus, is the most common sexually transmitted infection. According to the CDC, about 14 million people in US gets infected with HPV annually (“Human Papillomavirus” CDC). HPV is so common that it infects at least 75% of all people who are sexually active once during their lifetime (“Human Papillomavirus” Canadian Cancer Society). The infection with HPV usually occurs soon after the onset of sexual activity. This paper will cover what HPV is, its effects on the body and prevention.

Among the many arguments for mandatory HPV vaccination, the foremost is that it is an important medical achievement and a major public health milestone. This vaccine has proven to be one-hundred percent effective in preventing the 4 HPV strains that are responsible for seventy percent of cervical cancers and ninety percent of genital warts. In addition, no serious side effects have been identified. Because this vaccine is a preventive measure, administration before onset of sexual activity is ideal; however, even females who have been sexually active can still benefit from this vaccination (Perkins et al., 2010). Nationally and internationally, the HPV vaccine will significantly reduce disease burden by reducing monetary and psychological costs of invasive procedures that remove precancerous and cancerous lesions. By combining vaccination with routine Pap smear screening, these public health efforts have the remarkable opportunity to eradicate cervical cancer (Ramet et al., 2011).

Cervical cancer remains a public health problem that affects women worldwide. Cervical cancer is rated as the fourth type of cancer worldwide and the second most common cancer in women living in developing countries. In Europe, cervical cancer ranks as the sixth leading cancer of female cancers and second most common cancer among women aged between 15 to 44 years of age. Early detection and treatment are important for the prevention of morbidity and mortality related to cervical cancer. International studies conducted suggest that cervical cancer-related morbidity and mortality are highest among immigrant populations and that immigrant women may be less likely than non-immigrant women to participate in cervical cancer screening. These studies indicate that Somali women, in particular, constitute one immigrant group that is less likely to participate in cervical cancer screening. However, little information is known about the perceptions of and perspectives on cervical cancer screening as well as the barriers to uptake of cervical cancer screening among Somali women in Oslo. The aim of the study is to explore perceptions of and

Cervical disease is the fourth Largest basic cancer in women around the world, and second for ladies ages 15 to 44(Bailey et al., 2016). About 740 deaths for every day happen because of cervical cancer (Small et al., 2017), making it the second most regular reason for cancer demise in women (Chabra, 2016). This fact is anticipated to just ascent, with an expected 443,000 yearly deaths by 2030—a 67% growth and twice the normal maternal mortality from pregnancy inconveniences (Cervical Cancer Action, 2011).

Cervical cancer is cancer that starts in the cervix, which is the “lower, narrow end of the uterus.”2 This form of cancer occurs mostly in women who are older than thirty. The current estimate is 12,000 women in the U.S. who have cervical cancer and 4,000 deaths occur from it1. The main cause of cervical cancer is human papillomavirus (HPV), which is transmitted through sexual intercourse. Although these statistics seem high, cervical cancer is a rare form of cancer. Historically, cervical cancer was known as the “leading cause of cancer death for women in the U.S.”3. The number of women effected and the number of deaths have significantly decreased over the past 40 years due to various interventions.

A couple of systematic reviews addressing these issues have concluded that there is a need for improvement in the general knowledge about HPV infection and its role as a causative agent in cervical cancer (Cuschieri, Horne, Szarewski, & Cubie, 2006; Klug, Hukelmann, & Blettner, 2008). Studies conducted in adult women show that knowledge about HPV is generally low and that awareness is even lower among high school and college students. Of those who may be aware of HPV, they do not recognize its link with cervical cancer (Anhang, Goodman, & Goldie, 2004). Brewer & Fazekas (2007) used a collection of responses from various studies that specifically examined the awareness and knowledge of HPV to determine an estimate for the level of awareness of HPV among the general American population. While responses varied greatly across studies, approximately 42% of respondents were aware of HPV and 44% were able to correctly identify HPV as being a causative agent for cervical cancer (Brewer & Fazekas,

Cervical cancer is the second most common cancer among women and the leading cause of death among women in underdeveloped countries. In fact, 500,000 cases are diagnosed each year worldwide. This particular cancer is found mainly in middle-aged to older women; it is very rare to find it in women age fifteen and younger. The average age of women with cervical cancer is age 50-55; however, the cancer begins to appear in women in their twenties (2). It is also found in women of lower-class areas, as they are not able to see a gynecologist to be screened. African American, Hispanic, and Native American women are more prone to developing cervical cancer as well (1).